Sep 16, 2022 / 12:20PM GMT
Graham Glyn Charles Parry - BofA Securities, Research Division - MD and Head of Healthcare Equity Research
So thanks for staying with us after lunch. And as we sort of draw to the close of the presentations, it's my pleasure to be able to introduce Indivior. So some of you may be familiar with Indivior. But Mark Crossley is the CEO, and he is going to run through a presentation, just on the company opportunities in their opioid use disorder markets, and then we will open up for Q&A. So Mark, pleasure to have you here in London. The podium is all yours.
Mark Crossley - Indivior PLC - CEO & Executive Director
Thanks, Graham. Really appreciate it. Yes. Thanks again, Graham. And great to be here back in person. It seems like it's becoming more normal. I'll bypass the forward-looking statements, assuming everyone's read them. And let's just start with why Indivior. And I think the key here for those that don't know Indivior is we are the leaders in addiction. We're pioneering life-transforming treatments for both addiction and serious mental illness, where
Indivior PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers